Basecamp Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-142
Closed -$12.3K 1929
2026
Q1
$12.3K Sell
142
-380
-73% -$36.4K ﹤0.01% 959
2025
Q4
$50.1K Buy
+522
New +$50.7K 0.01% 534

Other funds holding MDT

Basecamp Wealth Advisors's MDT Position: Q2 2026 in Review

Basecamp Wealth Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 142 shares — an estimated $12.3K sold.

Basecamp Wealth Advisors first reported a position in MDT in Q4 2025 and held it in 2 quarters. The position peaked at $50.1K in Q4 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Basecamp Wealth Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Basecamp Wealth Advisors sold 142 Medtronic shares in Q2 2026, an estimated $12.3K.
  • Basecamp Wealth Advisors first reported a position in Medtronic in Q4 2025 and held it in 2 quarters.
  • Basecamp Wealth Advisors's Medtronic position peaked at $50.1K in Q4 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.